))
A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?”
Manage episode 309008730 series 3025226
Innhold levert av A Second Opinion Archives - WebTalkRadio.net. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av A Second Opinion Archives - WebTalkRadio.net eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Host TS Wiley interviews mainstream oncologist Julie Taguchi from Sansum Clinic in Santa Barbara, California on the memory loss attendant with estrogen deprivation and chemotherapy. In the interview they also cover the validity of big pharma testing on oncology drugs versus no treatment at all. This is a candid and frank interview with someone on the inside of the standard of care in breast cancer treatment. This isn’t a show you want to miss!
The post A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?” appeared first on WebTalkRadio.net.
20 episoder
Del
